Ohio State biotech spinoff targeting MD raises $182M in IPO
November 09, 2021 at 06:33 AM EST
An Ohio State University spinoff developing treatments for "undruggable" diseases has raised $181.5 million in an IPO.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|